X
28Jun

[Audio] Episode 148 -- A Review of the Novartis and Alcon FCPA Enforcement Action

Even during this difficult time of the pandemic, economic uncertainty and social unrest, the Justice Department and the SEC have concluded a major FCPA enforcement action. Novartis and Alcon (which was a Novartis subsidiary at the time of the misconduct) agreed to pay a total of $345 million in criminal and civil penalties. Novartis spun off Alcon in 2019. Under the DOJ settlement, Novartis and Alcon each entered into a deferred prosecution agreement; Novartis agreed to pay a fine of $225...
By: Michael Volkov
Source Url: https://www.jdsupra.com/legalnews/episode-148-a-review-of-the-novartis-40216/

Related

Third Circuit Examines FLSA ‘Willfulness’ Standard: ‘Reckless’ vs. ‘Egregious’

The issue of willfulness is very important in FLSA cases because such a finding extends the statute ...

Read More >

Real Estate Investor Pleads Guilty to Making False Statements Causing Financial Losses in Connection with Mortgage Loans

Recently, a real estate investor charged with bank fraud and making a false statement to a financial...

Read More >

The LHD/ERISA Advisor: Sixth Circuit Rejects MSPA and ERISA Discrimination Claims

Seeking to control healthcare costs, many group health plans have adopted amendments that lower reim...

Read More >

New merger control in Vietnam

On 24 March 2020, the Government of Vietnam promulgated Decree No. 35/2020/ND-CP setting forth, amon...

Read More >

A Guide to Second Requests in the Age of Analytics

Second Requests are high velocity, high volume, and high visibility — under normal circumstances. N...

Read More >

Philadelphia Fair Workweek Ordinance’s Effective Date Delayed Until April, 2020

On Friday, November 29, 2019, the Philadelphia Mayor’s Office of Labor postponed the effective date...

Read More >